Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5871)
All Articles published online
|
Publishing Process of This Article
|
Feb 16, 2015 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Madias JE. Is Takotsubo syndrome in patients receiving chemotherapy drug-specific? World J Clin Cases 2015; 3(2): 204-205 [PMID: 25685770 DOI: 10.12998/wjcc.v3.i2.204] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v3/i2/204.htm |
| Number | Citing Articles |
| 1 |
John E. Madias. The intriguing triangle of cancer, chemotherapy and takotsubo syndrome. Oxford Medical Case Reports 2016; 2016(8): omw058 doi: 10.1093/omcr/omw058
|
| 2 |
John E. Madias. What is/are the trigger(s) of takotsubo syndrome in cancer patients receiving chemotherapy?. International Journal of Cardiology 2016; 222: 253 doi: 10.1016/j.ijcard.2016.07.246
|
| 3 |
Matteo Coen, Fabio Rigamonti, Arnaud Roth, Thibaud Koessler. Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3384-4
|
| 4 |
Azzurra Irelli, Laura Ceriello, Leonardo Valerio Patruno, Alessandra Tessitore, Edoardo Alesse, Katia Cannita, Donatello Fabiani. Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer. Biomedicines 2024; 12(1): 179 doi: 10.3390/biomedicines12010179
|
| 5 |
H.A. Nati-Castillo, David Aristizabal-Colorado, Carolina López Ordoñez, Diego Egas Proaño, Esteban Ortiz-Prado, Juan S. Izquierdo-Condoy. Takotsubo syndrome as an acute cardiac complication following combined chemotherapy. International Journal of Cardiology Cardiovascular Risk and Prevention 2024; 22: 200292 doi: 10.1016/j.ijcrp.2024.200292
|